Clinical Trials Browser

OTHER × Interventional × Disease Progression × Clear all

NCT03586661 2026-03-11

Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase 1 Active not recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Disease Progression

NCT04205838 2026-02-27

Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma

Phase 2 Terminated

Lymphoma, Large B-Cell, Diffuse, Disease Progression

NCT07281833 2026-02-27

CAPIcorn

Phase 3 Recruiting

Breast Neoplasms, Neoplasm Metastasis, Disease Progression

NCT07369570 2026-02-24

REMRI

Phase NA Recruiting

Disease, Prostatic Neoplasms, Disease Progression

NCT04954820 2026-02-05

ReLUTH

Phase 2 Recruiting

Neuroendocrine Tumors, Disease Progression

NCT07274384 2025-12-10

HYPERBOLIC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Neoplasms, Disease Progression

NCT04974671 2025-12-04

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

Phase 2 Recruiting

Carcinoma, Renal Cell, Disease Progression

NCT04017650 2025-11-20

Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer

Phase 1/2 Active not recruiting

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Disease Progression

NCT07137871 2025-10-31

Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy

Phase 1 Recruiting

Disease Progression

NCT04300062 2025-09-03

REBIMMUNE

Phase NA Recruiting

Lung Neoplasms, Disease Progression

NCT07109323 2025-08-07

Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM

Phase 1/2 Recruiting

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Disease Progression

NCT07008716 2025-06-06

Omitting CTV for Primary Tumor in LS-SCLC

Phase 3 Recruiting

Radiation Injuries, Disease Progression

NCT01543763 2025-03-21

Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors

Phase 1 Completed

Neoplasm Metastasis, Sarcoma, Disease Progression

NCT05297734 2025-03-19

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Phase NA Recruiting

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicMyeloidSarcomaThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Death, Esophageal Neoplasms, Glioblastoma, Lung Diseases, Lung Neoplasms, Melanoma, Myelodysplastic Syndromes, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Sarcoma, Osteosarcoma, Skin Neoplasms, Stomach Neoplasms, Thoracic Neoplasms, Urogenital Neoplasms, Disease Progression, Small Cell Lung Carcinoma

NCT03154190 2025-01-24

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

Phase NA Completed

128 enrolled 24 charts

BreastDermatologicGastrointestinalGenitourinaryGynecologicMyeloidOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Bone Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Melanoma, Myelodysplastic Syndromes, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Stomach Neoplasms, Leukemia, Myeloid, Acute, Disease Progression, Triple Negative Breast Neoplasms

NCT01881620 2024-11-18

COMBITEP

Phase NA Completed

109 enrolled 12 charts

Disease Progression

NCT02043847 2024-11-13

BMT-03

Phase 1 Completed

12 enrolled 12 charts

Multiple Myeloma, Recurrence, Disease Progression

NCT06622174 2024-10-02

PROMISE

Phase 1 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Disease Progression

NCT03546426 2024-10-01

MESOVAX

Phase 1 Active not recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant, Disease Progression

NCT03422393 2024-07-05

Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib

Phase 1 Active not recruiting

LymphoidOther hematologic neoplasm

Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Disease Progression

NCT06472388 2024-06-25

EVENET

Phase 2 Recruiting

Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors, Disease Progression

NCT03374332 2024-02-08

Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia

Phase 2 Active not recruiting

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute, Disease Progression

NCT04029038 2023-08-21

Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or Lymphoma

Phase 1/2 Withdrawn

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasm, Residual, Disease Progression

NCT02135406 2023-06-22

CART-19 for Multiple Myeloma

Phase 1 Completed

Multiple Myeloma, Disease Progression

NCT04149821 2023-06-15

Umbralisib Plus Ublituximab (U2) in Progressive CLL After Novel Therapy

Phase 2 Terminated

1 enrolled 8 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Disease Progression

NCT05663242 2023-05-30

The Effects of Using Different Anesthetics on the Prognosis of Primary Lung Tumors and Its Mechanism of Action

Phase 4 Recruiting

Lung Neoplasms, Disease Progression

NCT02761070 2023-03-08

RE-GEND

Phase 3 Unknown

Glioblastoma, Recurrence, Disease Progression

NCT04005144 2022-10-17

Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Disease Progression

NCT04033432 2022-04-27

sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 2 Unknown

14 enrolled 13 charts

Prostatic Neoplasms, Disease Progression

NCT02817126 2022-03-22

REAL

Phase NA Unknown

Gastrointestinal

Intraoperative Complications, Postoperative Complications, Rectal Neoplasms, Recurrence, Disease Progression

NCT05146635 2022-01-11

Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial

Phase NA Unknown

Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT05184829 2022-01-11

A Single-center Study on the Effect of Systemic/Selective Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With Components With Consolidation/Tumor Ratio Between 0.5-1

Phase NA Not yet recruiting

Disease Progression

NCT04905056 2021-05-27

A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules

Phase 2 Recruiting

Disease Progression

NCT04044378 2020-05-19

Famitinib Plus Camrelizumab & Famitinib Alone & Famitinib Plus Ifosfamide in Advanced Osteosarcoma

Phase 1/2 Withdrawn

Neoplasms, Disease Progression

NCT02715297 2020-03-10

GlioCave/NOA17

Phase 2 Unknown

Glioblastoma, Disease Progression

NCT03715660 2019-11-21

Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study

Phase NA Completed

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT02538432 2019-11-04

Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors

Phase 2 Withdrawn

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Disease Progression

NCT03469804 2019-10-21

KAPKEY

Phase 2 Unknown

Sarcoma, Kaposi, Disease Progression

NCT01737450 2019-06-24

PIK-ORL

Phase 2 Completed

Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence, Disease Progression

NCT01191060 2019-04-18

IFM/DFCI2009

Phase 3 Completed

Disease Progression, Neoplasms, Plasma Cell

NCT02321202 2018-08-22

Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer

Phase 4 Completed

Gastrointestinal

Fibrosis, Hyperphagia, Liver Neoplasms, Disease Progression

NCT01355965 2017-09-19

Autologous Redirected RNA Meso-CIR T Cells

Phase 1 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Disease Progression

NCT03174912 2017-06-05

In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both?

Phase 4 Completed

Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT03138824 2017-05-23

Storz Professional Image Enhancement System Versus White Light Imaging Assisted TURBT for Treatment of NMIBC

Phase NA Unknown

Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT01886677 2017-03-03

Improving Energy Balance in Men With Prostate Cancer

Phase NA Completed

Motor Activity, Prostatic Neoplasms, Weight Loss, Disease Progression

NCT02319863 2014-12-18

Rapid Ligating the Corresponding Inflow and Outflow Vessels Without Hilus Dissection During Hepatectomy

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Disease Progression

NCT01959438 2013-10-10

SECAR

Phase 1/2 Unknown

Neoplasms, Disease Progression

NCT01210131 2013-08-27

HX4 in SCLC

Phase NA Withdrawn

Disease Progression, Small Cell Lung Carcinoma

NCT01340729 2013-04-05

Open-Label Study of TPI 287 for Patients With Metastatic Melanoma

Phase 1/2 Withdrawn

Melanoma, Recurrence, Disease Progression

NCT00530140 2011-10-06

FLIDVAX2006

Phase 2 Unknown

Lymphoma, Follicular, Disease Progression